26-Hydroxycholesterol

26-Hydroxycholesterol is a lipid of Sterol Lipids (ST) class. 26-hydroxycholesterol is associated with abnormalities such as Cardiovascular Diseases, Vascular Diseases, Metabolic syndrome, Obesity and Fatty Streak, Arterial. The involved functions are known as Oxidation, phospholipase activity, glucose metabolism, Binding (Molecular Function) and Regulation. 26-hydroxycholesterol often locates in Immune system, Body tissue, Extracellular, Protoplasm and Back. The associated genes with 26-Hydroxycholesterol are Homologous Gene, chylomicron remnant, Receptor Gene, Alleles and D3 compound. The related lipids are 27-hydroxycholesterol, Hydroxycholesterols, Lysophosphatidylcholines, Total cholesterol and Lipopolysaccharides. The related experimental models are Knock-out and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of 26-Hydroxycholesterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 26-Hydroxycholesterol?

26-Hydroxycholesterol is suspected in hypercholesterolemia, Obesity, Atherosclerosis, Metabolic syndrome, Neurodegenerative Disorders, Dyslipidemias and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 26-Hydroxycholesterol

MeSH term MeSH ID Detail
Inflammation D007249 119 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Alzheimer Disease D000544 76 associated lipids
Alcoholism D000437 27 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 26-Hydroxycholesterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 26-Hydroxycholesterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 26-Hydroxycholesterol?

Transgenic Model

Transgenic Model are used in the study 'Cholesterol and breast cancer pathophysiology.' (Nelson ER et al., 2014) and Transgenic Model are used in the study 'Obesity, cholesterol metabolism, and breast cancer pathogenesis.' (McDonnell DP et al., 2014).

Knock-out

Knock-out are used in the study 'The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha.' (Umetani M et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 26-Hydroxycholesterol

Download all related citations
Per page 10 20 50 100 | Total 403
Authors Title Published Journal PubMed Link
pmid:
Duane WC and Javitt NB 27-hydroxycholesterol: production rates in normal human subjects. 1999 J. Lipid Res. pmid:10393204
Babiker A et al. Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin. 1999 J. Lipid Res. pmid:10428977
Wu Z et al. Structure and functions of human oxysterol 7alpha-hydroxylase cDNAs and gene CYP7B1. 1999 J. Lipid Res. pmid:10588945
Li-Hawkins J et al. Expression cloning of an oxysterol 7alpha-hydroxylase selective for 24-hydroxycholesterol. 2000 J. Biol. Chem. pmid:10748047
Li S et al. Kinetics and plasma concentrations of 26-hydroxycholesterol in baboons. 2000 Biochim. Biophys. Acta pmid:10832098
Norlin M et al. Oxysterol 7 alpha-hydroxylase activity by cholesterol 7 alpha-hydroxylase (CYP7A). 2000 J. Biol. Chem. pmid:10882719
D'Ambra TE et al. Oxysterols: 27-hydroxycholesterol and its radiolabeled analog. 2000 Steroids pmid:10899540
Li D and Spencer TA Synthesis of 7alpha-hydroxy derivatives of regulatory oxysterols. 2000 Steroids pmid:10978732
Norlin M et al. 24-hydroxycholesterol is a substrate for hepatic cholesterol 7alpha-hydroxylase (CYP7A). 2000 J. Lipid Res. pmid:11013305
Russell DW Oxysterol biosynthetic enzymes. 2000 Biochim. Biophys. Acta pmid:11111082
Javitt NB Biologic role(s) of the 25(R),26-hydroxycholesterol metabolic pathway. 2000 Biochim. Biophys. Acta pmid:11111083
Christenson LK et al. Conditional response of the human steroidogenic acute regulatory protein gene promoter to sterol regulatory element binding protein-1a. 2001 Endocrinology pmid:11145563
Meaney S et al. Evidence that the major oxysterols in human circulation originate from distinct pools of cholesterol: a stable isotope study. 2001 J. Lipid Res. pmid:11160367
Shanahan CM et al. A potential role for sterol 27-hydroxylase in atherogenesis. 2001 Atherosclerosis pmid:11166758
Honda A et al. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX. 2001 J. Lipid Res. pmid:11181760
Björkhem I et al. Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol. 2001 J. Lipid Res. pmid:11254748
Del Puppo M et al. Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration. 2001 J. Lipid Res. pmid:11254756
Yasunobu Y et al. Coronary atherosclerosis and oxidative stress as reflected by autoantibodies against oxidized low-density lipoprotein and oxysterols. 2001 Atherosclerosis pmid:11254916
Zhang Z et al. Key regulatory oxysterols in liver: analysis as delta4-3-ketone derivatives by HPLC and response to physiological perturbations. 2001 J. Lipid Res. pmid:11290837
Hall E et al. Overexpression of CYP27 in hepatic and extrahepatic cells: role in the regulation of cholesterol homeostasis. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11408283
Lütjohann D et al. Cholesterol dynamics in the foetal and neonatal brain as reflected by circulatory levels of 24S-hydroxycholesterol. 2001 Acta Paediatr. pmid:11440099
Bertolotti M et al. Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans. 2001 Hepatology pmid:11481606
Fu X et al. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. 2001 J. Biol. Chem. pmid:11504730
Bodin K et al. Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4. 2001 J. Biol. Chem. pmid:11514559
Reiss AB et al. Immune complexes and IFN-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages. 2001 J. Lipid Res. pmid:11714861
Upston JM et al. Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis. 2002 Am. J. Pathol. pmid:11839591
Rosklint T et al. Oxysterols induce interleukin-1beta production in human macrophages. 2002 Eur. J. Clin. Invest. pmid:11851725
Duane WC and Javitt NB Conversion of 7 alpha-hydroxycholesterol to bile acid in human subjects: is there an alternate pathway favoring cholic acid synthesis? 2002 J. Lab. Clin. Med. pmid:11919549
Norlin M Expression of key enzymes in bile acid biosynthesis during development: CYP7B1-mediated activities show tissue-specific differences. 2002 J. Lipid Res. pmid:11971943
Pandak WM et al. Regulation of oxysterol 7alpha-hydroxylase (CYP7B1) in primary cultures of rat hepatocytes. 2002 Hepatology pmid:12029625
von Bahr S et al. Mechanism of accumulation of cholesterol and cholestanol in tendons and the role of sterol 27-hydroxylase (CYP27A1). 2002 Arterioscler. Thromb. Vasc. Biol. pmid:12117727
Meir K et al. Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. 2002 J. Biol. Chem. pmid:12119285
Oyama T et al. Effect of deposited lipids in atheromatous lesions on the migration of vascular smooth muscle cells. 2002 J. Atheroscler. Thromb. pmid:12236314
Pandak WM et al. Transport of cholesterol into mitochondria is rate-limiting for bile acid synthesis via the alternative pathway in primary rat hepatocytes. 2002 J. Biol. Chem. pmid:12368294
Williams JR et al. Synthesis of (25R)-26-hydroxycholesterol. 2002 Steroids pmid:12441189
Meaney S et al. On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function. 2002 J. Lipid Res. pmid:12454275
Teunissen CE et al. Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. 2003 Jan-Feb Neurobiol. Aging pmid:12493560
Jabara S et al. Stromal cells of the human postmenopausal ovary display a distinctive biochemical and molecular phenotype. 2003 J. Clin. Endocrinol. Metab. pmid:12519894
Escher G et al. Expression of sterol 27-hydroxylase (CYP27A1) enhances cholesterol efflux. 2003 J. Biol. Chem. pmid:12531903
Leoni V et al. Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers. 2003 J. Lipid Res. pmid:12562838
Hansson M et al. Marked induction of sterol 27-hydroxylase activity and mRNA levels during differentiation of human cultured monocytes into macrophages. 2003 Biochim. Biophys. Acta pmid:12581873
Frolov A et al. NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols. 2003 J. Biol. Chem. pmid:12719428
Wassif CA et al. 27-Hydroxylation of 7- and 8-dehydrocholesterol in Smith-Lemli-Opitz syndrome: a novel metabolic pathway. 2003 Steroids pmid:12906934
Meaney S et al. On the origin of the cholestenoic acids in human circulation. 2003 Steroids pmid:12957664
FREDRICKSON DS and ONO K The in vitro production of 25- and 26-hydroxycholesterol and their in vivo metabolism. 1956 Biochim. Biophys. Acta pmid:13373861
Björkhem I et al. 7 alpha-hydroxylation of 27-hydroxycholesterol in human liver microsomes. 1992 Biochim. Biophys. Acta pmid:1390879
Heverin M et al. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. 2004 J. Lipid Res. pmid:14523054
Tuomainen TP et al. Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man. 2003 Free Radic. Biol. Med. pmid:14556856
Yoshida T et al. Origin of oxysterols in hepatic bile of patients with biliary infection. 2003 Am. J. Gastroenterol. pmid:14572579
Souidi M et al. Effects of dietary 27-hydroxycholesterol on cholesterol metabolism and bile acid biosynthesis in the hamster. 2003 Can. J. Physiol. Pharmacol. pmid:14614521
Zhang J et al. The steroidal analog GW707 activates the SREBP pathway through disruption of intracellular cholesterol trafficking. 2004 J. Lipid Res. pmid:14617742
Pikuleva I and Javitt NB Novel sterols synthesized via the CYP27A1 metabolic pathway. 2003 Arch. Biochem. Biophys. pmid:14622972
Ciuffreda P et al. Synthesis of deuterated isotopomers of 7alpha- and (25R,S)-26-hydroxycholesterol, internal standards for in vivo determination of the two biosynthetic pathways of bile acids. 2003 Steroids pmid:14625005
Strömsten A et al. Studies on the mechanism of accumulation of cholesterol in the gallbladder mucosa. Evidence that sterol 27-hydroxylase is not a pathogenetic factor. 2004 J. Hepatol. pmid:14672608
Honda A et al. Significance of plasma 7alpha-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits. 2004 Metab. Clin. Exp. pmid:14681840
Guan JZ et al. Clofibrate, a peroxisome-proliferator, enhances reverse cholesterol transport through cytochrome P450 activation and oxysterol generation. 2003 Tohoku J. Exp. Med. pmid:14690017
Burkard I et al. Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry. 2004 J. Lipid Res. pmid:14729854
Leoni V et al. Diagnostic use of cerebral and extracerebral oxysterols. 2004 Clin. Chem. Lab. Med. pmid:15061359
Brown J et al. Differential expression of cholesterol hydroxylases in Alzheimer's disease. 2004 J. Biol. Chem. pmid:15148325
Zhou Q et al. 27-Hydroxycholesterol inhibits neutral sphingomyelinase in cultured human endothelial cells. 2004 Life Sci. pmid:15261762
Szanto A et al. Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. 2004 Mol. Cell. Biol. pmid:15340076
Holdenrieder S et al. Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke? 2004 Neurosci. Lett. pmid:15351449
Kölsch H et al. Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. 2004 Neurosci. Lett. pmid:15364416
Matyash V et al. Sterol-derived hormone(s) controls entry into diapause in Caenorhabditis elegans by consecutive activation of DAF-12 and DAF-16. 2004 PLoS Biol. pmid:15383841
Meaney S et al. Serum cholestenoic acid as a potential marker of pulmonary cholesterol homeostasis: increased levels in patients with pulmonary alveolar proteinosis. 2004 J. Lipid Res. pmid:15466366
Davies JD et al. Adipocytic differentiation and liver x receptor pathways regulate the accumulation of triacylglycerols in human vascular smooth muscle cells. 2005 J. Biol. Chem. pmid:15548517
Alessandrini L et al. Clemmensen reduction of diosgenin and kryptogenin: synthesis of [16,16,22,22,23,23-(2)H(6)]-(25R)-26-hydroxycholesterol. 2004 Steroids pmid:15582533
Hansson M et al. Regulation of sterol 27-hydroxylase in human monocyte-derived macrophages: up-regulation by transforming growth factor beta1. 2005 Biochim. Biophys. Acta pmid:15708352
Heverin M et al. Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain. 2005 J. Lipid Res. pmid:15741649
von Bahr S et al. Mutation in the sterol 27-hydroxylase gene associated with fatal cholestasis in infancy. 2005 J. Pediatr. Gastroenterol. Nutr. pmid:15795599
Del Puppo M et al. A minimally invasive technique for the evaluation of the regulatory steps of the two major pathways of bile acid synthesis. 2005 Clin. Chim. Acta pmid:15820474
Hall EA et al. Detection of the steroidogenic acute regulatory protein, StAR, in human liver cells. 2005 Biochim. Biophys. Acta pmid:15863358
Bohr IJ Does cholesterol act as a protector of cholinergic projections in Alzheimer's disease? 2005 Lipids Health Dis pmid:15949039
Meaney S Is C-26 hydroxylation an evolutionarily conserved steroid inactivation mechanism? 2005 FASEB J. pmid:16051688
Babiker A et al. Patients with atherosclerosis may have increased circulating levels of 27-hydroxycholesterol and cholestenoic acid. 2005 Scand. J. Clin. Lab. Invest. pmid:16081359
Zhu Y et al. Oxidized LDL downregulates ATP-binding cassette transporter-1 in human vascular endothelial cells via inhibiting liver X receptor (LXR). 2005 Cardiovasc. Res. pmid:16099444
Lemaire-Ewing S et al. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. 2005 Cell Biol. Toxicol. pmid:16142584
Kummerow FA et al. 27-Hydroxycholesterol causes remodeling in endothelial cell membrane lipid composition comparable to remodeling in the failed vein grafts of CABG patients. 2006 Life Sci. pmid:16154158
Guéguen Y et al. Short-term hepatic effects of depleted uranium on xenobiotic and bile acid metabolizing cytochrome P450 enzymes in the rat. 2006 Arch. Toxicol. pmid:16231126
Pinkerton FD et al. Synergistic action of two oxysterols in the lowering of HMG-CoA reductase activity in CHO-K1 cells. 1992 Biochem. Biophys. Res. Commun. pmid:1632792
Thelen KM et al. Effect of pravastatin on plasma sterols and oxysterols in men. 2006 Eur. J. Clin. Pharmacol. pmid:16385401
Pikuleva IA Cholesterol-metabolizing cytochromes P450. 2006 Drug Metab. Dispos. pmid:16434543
Hall EA et al. Mitochondrial cholesterol transport: a possible target in the management of hyperlipidemia. 2005 Lipids pmid:16477808
Klass DM et al. Biliary lipids, cholesterol and bile synthesis: different adaptive mechanisms to dietary cholesterol in lean and obese subjects. 2006 Aliment. Pharmacol. Ther. pmid:16573792
Gong H and Williams JR Synthesis of the aglycone of the shark repellent pavoninin-4 using remote functionalization. 2006 Org. Lett. pmid:16706499
Thelen KM et al. High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. 2006 J Clin Pharmacol pmid:16809807
Björkhem I et al. Oxysterols and Alzheimer's disease. 2006 Acta Neurol. Scand., Suppl.c pmid:16866910
Larsson DA et al. Oxysterol mixtures, in atheroma-relevant proportions, display synergistic and proapoptotic effects. 2006 Free Radic. Biol. Med. pmid:16934673
Holzapfel J et al. PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease. 2006 Neurosci. Lett. pmid:16979821
Dushkin MI et al. Effects of hydroxysterols and atorvastatin on lipopolysaccharide-induced secretion of tumor necrosis factor and interleukin-10 by mouse macrophages. 2006 Bull. Exp. Biol. Med. pmid:16984105
Luomala M et al. Plasma-soluble CD40 is related to cholesterol metabolism in patients with moderate hypercholesterolemia. 2006 Scand. Cardiovasc. J. pmid:17012138
Rojo L et al. Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease. 2006 J. Biomed. Biotechnol. pmid:17047312
Li T et al. PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. 2007 J. Lipid Res. pmid:17088262
Burkard I et al. Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers. 2007 Atherosclerosis pmid:17107679
Björkhem I Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. 2006 J. Intern. Med. pmid:17116000
Jiang X et al. Characterization of oxysterols by electrospray ionization tandem mass spectrometry after one-step derivatization with dimethylglycine. 2007 Rapid Commun. Mass Spectrom. pmid:17154356
Chen W et al. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. 2007 Cell Metab. pmid:17189208
Meaney S et al. Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7alpha-hydroxy-3-oxo-4-cholestenoic acid. 2007 J. Lipid Res. pmid:17251592
Toll A et al. 7 alpha-hydroxylation of 26-hydroxycholesterol, 3 beta-hydroxy-5-cholestenoic acid and 3 beta-hydroxy-5-cholenoic acid by cytochrome P-450 in pig liver microsomes. 1992 FEBS Lett. pmid:1730295